vs

Side-by-side financial comparison of BADGER METER INC (BMI) and Cellebrite DI Ltd. (CLBT). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $234.1M, roughly 1.2× BADGER METER INC). BADGER METER INC runs the higher net margin — 14.3% vs -103.5%, a 117.8% gap on every dollar of revenue. Cellebrite DI Ltd. produced more free cash flow last quarter ($60.8M vs $50.8M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 9.2%).

Badger Meter Inc. is a leading global provider of flow measurement and control solutions, serving water utilities, industrial, commercial, and residential customer segments. Its core offerings include smart water meters, IoT-enabled usage monitoring systems, and supporting software that help clients track resource consumption, cut waste, and boost operational efficiency, with key markets spanning North America, Europe, and the Asia-Pacific region.

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

BMI vs CLBT — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.2× larger
CLBT
$292.2M
$234.1M
BMI
Higher net margin
BMI
BMI
117.8% more per $
BMI
14.3%
-103.5%
CLBT
More free cash flow
CLBT
CLBT
$10.0M more FCF
CLBT
$60.8M
$50.8M
BMI
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
9.2%
BMI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BMI
BMI
CLBT
CLBT
Revenue
$234.1M
$292.2M
Net Profit
$33.6M
$-302.3M
Gross Margin
39.7%
84.6%
Operating Margin
18.4%
14.1%
Net Margin
14.3%
-103.5%
Revenue YoY
14.1%
Net Profit YoY
9.3%
EPS (diluted)
$1.13
$-1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMI
BMI
CLBT
CLBT
Q4 25
$234.1M
Q3 25
$222.2M
$292.2M
Q2 25
$238.1M
$220.8M
Q1 25
$222.2M
$89.6M
Q4 24
$205.2M
Q3 24
$208.4M
$232.1M
Q2 24
$216.7M
$185.3M
Q1 24
$196.3M
$71.2M
Net Profit
BMI
BMI
CLBT
CLBT
Q4 25
$33.6M
Q3 25
$35.1M
$-302.3M
Q2 25
$34.6M
$36.9M
Q1 25
$38.4M
$-71.4M
Q4 24
$30.7M
Q3 24
$32.0M
Q2 24
$33.1M
$-95.2M
Q1 24
$29.1M
$-40.6M
Gross Margin
BMI
BMI
CLBT
CLBT
Q4 25
39.7%
Q3 25
43.1%
84.6%
Q2 25
41.1%
84.1%
Q1 25
42.9%
85.2%
Q4 24
40.3%
Q3 24
40.2%
83.5%
Q2 24
39.4%
84.1%
Q1 24
39.3%
82.6%
Operating Margin
BMI
BMI
CLBT
CLBT
Q4 25
18.4%
Q3 25
20.7%
14.1%
Q2 25
18.8%
12.1%
Q1 25
22.2%
10.3%
Q4 24
19.1%
Q3 24
19.5%
7.9%
Q2 24
19.2%
11.7%
Q1 24
18.6%
0.2%
Net Margin
BMI
BMI
CLBT
CLBT
Q4 25
14.3%
Q3 25
15.8%
-103.5%
Q2 25
14.5%
16.7%
Q1 25
17.3%
-79.7%
Q4 24
15.0%
Q3 24
15.4%
Q2 24
15.3%
-51.4%
Q1 24
14.8%
-57.0%
EPS (diluted)
BMI
BMI
CLBT
CLBT
Q4 25
$1.13
Q3 25
$1.19
$-1.50
Q2 25
$1.17
$0.15
Q1 25
$1.30
$-0.36
Q4 24
$1.04
Q3 24
$1.08
$-0.35
Q2 24
$1.12
$-0.48
Q1 24
$0.99
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMI
BMI
CLBT
CLBT
Cash + ST InvestmentsLiquidity on hand
$191.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$713.3M
$336.0M
Total Assets
$973.6M
$690.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMI
BMI
CLBT
CLBT
Q4 25
Q3 25
$191.7M
Q2 25
$326.1M
Q1 25
$191.7M
Q4 24
Q3 24
$189.5M
Q2 24
$178.6M
Q1 24
$189.5M
Stockholders' Equity
BMI
BMI
CLBT
CLBT
Q4 25
$713.3M
Q3 25
$702.5M
$336.0M
Q2 25
$677.6M
$408.4M
Q1 25
$641.7M
$336.0M
Q4 24
$606.2M
Q3 24
$591.2M
$34.2M
Q2 24
$563.1M
$-40.2M
Q1 24
$535.6M
$34.2M
Total Assets
BMI
BMI
CLBT
CLBT
Q4 25
$973.6M
Q3 25
$978.3M
$690.6M
Q2 25
$936.4M
$787.4M
Q1 25
$899.6M
$690.6M
Q4 24
$816.4M
Q3 24
$802.9M
$532.9M
Q2 24
$781.3M
$556.6M
Q1 24
$743.5M
$532.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMI
BMI
CLBT
CLBT
Operating Cash FlowLast quarter
$54.8M
$66.2M
Free Cash FlowOCF − Capex
$50.8M
$60.8M
FCF MarginFCF / Revenue
21.7%
20.8%
Capex IntensityCapex / Revenue
1.7%
1.8%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$169.7M
$172.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMI
BMI
CLBT
CLBT
Q4 25
$54.8M
Q3 25
$51.3M
$66.2M
Q2 25
$44.6M
$53.5M
Q1 25
$33.0M
$10.0M
Q4 24
$52.1M
Q3 24
$45.1M
$58.2M
Q2 24
$36.4M
$24.6M
Q1 24
$21.5M
$12.5M
Free Cash Flow
BMI
BMI
CLBT
CLBT
Q4 25
$50.8M
Q3 25
$48.2M
$60.8M
Q2 25
$40.6M
$47.5M
Q1 25
$30.1M
$8.5M
Q4 24
$47.4M
Q3 24
$42.0M
$55.3M
Q2 24
$34.1M
$21.0M
Q1 24
$18.8M
$11.4M
FCF Margin
BMI
BMI
CLBT
CLBT
Q4 25
21.7%
Q3 25
21.7%
20.8%
Q2 25
17.1%
21.5%
Q1 25
13.5%
9.5%
Q4 24
23.1%
Q3 24
20.1%
23.8%
Q2 24
15.7%
11.3%
Q1 24
9.6%
16.0%
Capex Intensity
BMI
BMI
CLBT
CLBT
Q4 25
1.7%
Q3 25
1.4%
1.8%
Q2 25
1.7%
2.7%
Q1 25
1.3%
1.7%
Q4 24
2.3%
Q3 24
1.5%
1.3%
Q2 24
1.1%
1.9%
Q1 24
1.4%
1.5%
Cash Conversion
BMI
BMI
CLBT
CLBT
Q4 25
1.63×
Q3 25
1.46×
Q2 25
1.29×
1.45×
Q1 25
0.86×
Q4 24
1.70×
Q3 24
1.41×
Q2 24
1.10×
Q1 24
0.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMI
BMI

Transferred At Point In Time$198.6M85%
Transferred Over Time$22.1M9%
Other$13.4M6%

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

Related Comparisons